Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery

International Journal of Pharmaceutics

Volumn 397, Issue 1-2, 2010, Pages 164-172

  El Zaafarany, Ghada M ^a   Awad, Gehanne A S ^a   Holayel, Samar M ^a   Mortada, Nahed D ^a  

^a Ain Shams University   (Egypt)

Author keywords

Deformability; Diclofenac sodium; Edge activators; Enhanced skin delivery; Transfersomes; Ultraflexible lipid vesicles

Indexed keywords

CHOLIC ACID; DEOXYCHOLATE SODIUM; DICLOFENAC; DRUG CARRIER; POLYSORBATE 80; SORBITAN OLEATE; SORBITAN TRIOLEATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG PENETRATION; DRUG RELEASE; DRUG STABILITY; ELECTRON MICROSCOPY; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SKIN PERMEABILITY; SURFACE CHARGE;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; LIPOSOMES; MALE; PARTICLE SIZE; POLYSORBATES; RABBITS; SKIN; SKIN ABSORPTION; SONICATION; SURFACE PROPERTIES;

EID: 77955980602     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.06.034     Document Type: Article

References (56)

1. Arica B., Ozer A.Y., Ercan M.T., Hincal A.A. Characterization, in vitro and in vivo studies on primaquine diphosphate liposomes. J. Microencapsul. 1995, 12:469-485.
2. Bahia A.P., Azevedo E.G., Ferreira L.A.M., Frθzard F. New insights into the mode of action of ultradeformable vesicles using calcein as hydrophilic fluorescent marker. Eur. J. Pharm. Sci. 2010, 39:90-96.
3. Bartolomei M., Bertocchi P., Antoniella E., Rodomonte A. Physico-chemical characterisation and intrinsic dissolution studies of a new hydrate form of Diclofenac sodium: comparison with anhydrous form. J. Pharm. Biomed. Anal. 2006, 40:1105-1113.
4. Boinpally R.R., Zhou S.L., Poondru S., Devraj G., Jasti B.R. Lecithin vesicles for topical delivery of Diclofenac. Eur. J. Pharm. Biopharm. 2003, 56:389-392.
5. Cevc G. Transdermal drug delivery of insulin with ultradeformable carriers. Clin. Pharmacokinet. 2003, 42:461-474.
6. Cevc G., Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim. Biophys. Acta 1992, 1104:226-232.
7. Cevc G., Vierl U., Mazgareanu S. Functional characterisation of novel analgesic product based on self-regulating drug carriers. Int. J. Pharm. 2008, 360:18-28.
8. Cevc G., Blume G. New, highly efficient formulation of Diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim. Biophys. Acta 2001, 1514:191-205.
9. Cevc G., Blume G. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes. Biochim. Biophys. Acta 2003, 1614:156-164.
10. Cevc G., Blume G. Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim. Biophys. Acta 2004, 1663:61-73.
11. Cevc G., Blume G., SchAtzlein A. Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo. J. Control. Release 1997, 45:211-226.
12. Cevc G., Blume G., SchAtzlein A., Gebauer D., Paul A. The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Adv. Drug Deliv. Rev. 1996, 18:349-378.
13. Cevc G., Gebauer D. Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier. Biophys. J. 2003, 84:1010-1024.
14. Cevc G., Gebauer D., Stieber J., SchAtzlein A., Blume G. Ultraflexible vesicles. Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim. Biophys. Acta 1998, 1368:201-215.
15. Cevc G., SchAtzlein A., Blume G. Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J. Control. Release 1995, 36:3-16.
16. Dragicevic-Curic N., GrAfe S., Gitter B., Winter S., Fahr A. Surface charged temoporfin-loaded flexible vesicles: In vitro skin penetration studies and stability. Int. J. Pharm. 2010, 384:100-108.
17. El Maghraby G.M., Barry B.W., Williams A.C. Liposomes and skin: from drug delivery to model membranes. Eur. J. Pharm. Sci. 2008, 34:203-222.
18. El Maghraby G.M., Williams A.C., Barry B.W. Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro. J. Pharm. Pharmacol. 2001, 53:1069-1077.
19. El Maghraby G.M., Williams A.C., Barry B.W. Can drug-bearing liposomes penetrate intact skin?. J. Pharm. Pharmacol. 2006, 58:415-429.
20. El Maghraby G.M.M., Williams A.C., Barry B.W. Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int. J. Pharm. 2000, 204:159-169.
21. El Maghraby G.M.M., Williams A.C., Barry B.W. Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int. J. Pharm. 2000, 196:63-74.
22. Elsayed M.M.A., Abdallah O.Y., Naggar V.F., Khalafallah N.M. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int. J. Pharm. 2006, 322:60-66.
23. Elsayed M.M.A., Abdallah O.Y., Naggar V.F., Khalafallah N.M. Lipid vesicles for skin delivery of drugs: Reviewing three decades of research. Int. J. Pharm. 2007, 332:1-16.
24. Escribano E., Calpena A.C., Queralt J., Obach R., Domθnech J. Assessment of Diclofenac permeation with different formulations: anti-inflammatory study of a selected formula. Eur. J. Pharm. Sci. 2003, 19:203-210.
25. Fang J.Y., Hong C.T., Chiu W.T., Wang Y.Y. Effect of liposomes and niosomes on skin permeation of enoxacin. Int. J. Pharm. 2001, 219:61-72.
26. Guinedi A.S., Mortada N.D., Mansour S., Hathout R.M. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int. J. Pharm. 2005, 306:71-82.
27. Gupta P.N., Mishra V., Rawat A., Dubey P., Mahor S., Jain S., Chatterji D.P., Vyas S.P. Non-invasive vaccine delivery in Transfersomes, niosomes and liposomes: a comparative study. Int. J. Pharm. 2005, 293:73-82.
28. Hathout R.M., Mansour S., Mortada N.D., Guinedi A.S. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS Pharm. Sci. Tech. 2007, 8:1.
29. Hiruta Y., Hattori Y., Kawano K., Obata Y., Maitani Y. Novel ultra-deformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin. J. Control. Release 2006, 113:146-154.
30. Hofer C., van Randenborgh H., Lehmer A., Hartung R., Breul J.r. Transcutaneous IL-2 uptake mediated by Transfersomes« depends on concentration and fractionated application. Cytokine 2004, 25:141-146.
31. Honeywell-Nguyen P.L., Arenja S., Bouwstra J.A. Skin penetration and mechanisms of action in the delivery of the D2-agonist rotigotine from surfactant-based elastic vesicle formulations. Pharm. Res. 2003, 20:1619-1625.
32. Honeywell-Nguyen P.L., Bouwstra J.A. Vesicles as a tool for transdermal and dermal delivery. Drug Discov. Today: Technol. 2005, 2:67-74.
33. Honeywell-Nguyen P.L., Bouwstra J.A. The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of action. J. Control. Release 2003, 86:145-156.
34. Jain S., Jain P., Umamaheshwari R.B., Jain N.K. Transfersomes--a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev. Ind. Pharm. 2003, 29:1013-1026.
35. Kim A., Lee E.H., Choi S.H., Kim C.K. In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome. Biomaterials 2004, 25:305-313.
36. Lee E.H., Kim A., Oh Y.K., Kim C.K. Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. Biomaterials 2005, 26:205-210.
37. Li L., Hoffman R.M. Topical liposome delivery of molecules to hair follicles in mice. J. Dermatol. Sci. 1997, 14:101-108.
38. Lopes L.B., Scarpa M.V., Silva G.V.J., Rodrigues D.C., Santilli C.V., Oliveira A.G. Studies on the encapsulation of Diclofenac in small unilamellar liposomes of soya phosphatidylcholine. Colloids Surf. B: Biointerfaces 2004, 39:151-158.
39. Maestrelli F., Gonzβlez-Rodrguez M.L., Rabasco A.M., Mura P. Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery. Int. J. Pharm. 2005, 298:55-67.
40. Manconi M., Mura S., Sinico C., Fadda A.M., Vila A.O., Molina F. Development and characterization of liposomes containing glycols as carriers for Diclofenac. Colloids Surf. A: Physicochem. Eng. Asp. 2009, 342:53-58.
41. Manconi M., Valenti D., Sinico C., Lai F., Loy G., Fadda A.M. Niosomes as carriers for tretinoin: II. Influence of vesicular incorporation on tretinoin photostability. Int. J. Pharm. 2003, 260:261-272.
42. Manosroi A., Jantrawut P., Manosroi J. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with Diclofenac diethylammonium. Int. J. Pharm. 2008, 360:156-163.
43. Mokhtar M., Sammour O.A., Hammad M.A., Megrab N.A. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int. J. Pharm. 2008, 361:104-111.
44. Montanari J., Roncaglia D.I., Lado L.A., Morilla M.J., Romero E.L. Avoiding failed reconstitution of ultradeformable liposomes upon dehydration. Int. J. Pharm. 2009, 372:184-190.
45. Nasr M., Mansour S., Mortada N.D., Elshamy A.A. Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J. Microencapsul. 2008, 25:499-512.
46. Ning M.Y., Guo Y.Z., Pan H.Z., Yu H.M., Gu Z.W. Preparation and evaluation of proliposomes containing clotrimazole. Chem. Pharm. Bull. (Tokyo) 2005, 53:620-624.
47. Paul A., Cevc G., Bachhawat B.K. Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, Transfersomes. Vaccine 1998, 16:188-195.
48. Paul A., Cevc G., Bachhawat B.K. Transdermal immunization with large proteins by means of ultradeformable drug carriers. Eur. J. Immunol. 1995, 25:3521-3524.
49. Song Y.K., Kim C.K. Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes. Biomaterials 2006, 27:271-280.
50. Subuddhi U., Mishra A.K. Micellization of bile salts in aqueous medium: a fluorescence study. Colloids Surf. B Biointerfaces 2007, 57:102-107.
51. Touitou E., Dayan N., Bergelson L., Godin B., Eliaz M. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J. Control. Release 2000, 65:403-418.
52. Trotta M., Peira E., Debernardi F., Gallarate M. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int. J. Pharm. 2002, 241:319-327.
53. Trotta M., Peira E., Carlotti M.E., Gallarate M. Deformable liposomes for dermal administration of methotrexate. Int. J. Pharm. 2004, 270:119-125.
54. Van den Bergh B.A.I., Wertz P.W., Junginger H.E., Bouwstra J.A. Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. Int. J. Pharm. 2001, 217:13-24.
55. Verma D.D., Verma S., Blume G., Fahr A. Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. Eur. J. Pharm. Biopharm. 2003, 55:271-277.
56. Yoshioka T., Sternberg B., Florence A.T. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85). Int. J. Pharm. 1994, 105:1-6.